{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T12:45:35Z","timestamp":1772196335939,"version":"3.50.1"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1016\/j.vaccine.2005.01.103","type":"journal-article","created":{"date-parts":[[2005,2,8]],"date-time":"2005-02-08T15:15:25Z","timestamp":1107875725000},"page":"S11-S12","source":"Crossref","is-referenced-by-count":7,"special_numbering":"S2","title":["Reverse vaccinology \u2014 In search of a genome-derived meningococcal vaccine"],"prefix":"10.1016","volume":"24","author":[{"given":"Lisa","family":"Danzig","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2005.01.103_bib1","first-page":"195","article-title":"Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba","volume":"14","author":"Sierra","year":"1991","journal-title":"NIPH Ann"},{"key":"10.1016\/j.vaccine.2005.01.103_bib2","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/0140-6736(91)91961-S","article-title":"Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway","volume":"338","author":"Bjune","year":"1991","journal-title":"Lancet"},{"issue":"16","key":"10.1016\/j.vaccine.2005.01.103_bib3","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1001\/jama.281.16.1520","article-title":"Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile","volume":"281","author":"Tappero","year":"1999","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.vaccine.2005.01.103_bib4","first-page":"17","article-title":"The genome revolution in vaccine research","volume":"6","author":"Capecchi","year":"2004","journal-title":"Curr Issues Mol Biol"},{"issue":"5459","key":"10.1016\/j.vaccine.2005.01.103_bib5","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1126\/science.287.5459.1816","article-title":"Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing","volume":"287","author":"Pizza","year":"2000","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.vaccine.2005.01.103_bib6","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1084\/jem.20020407","article-title":"NadA, a novel vaccine candidate of Neisseria meningitidis","volume":"195","author":"Comanducci","year":"2002","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.vaccine.2005.01.103_bib7","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1046\/j.1365-2958.2003.03420.x","article-title":"Neisseria meningitidis App, a new adhesin with autocatalytic serine protease activity","volume":"48","author":"Serruto","year":"2003","journal-title":"Mol Microbiol"},{"issue":"11","key":"10.1016\/j.vaccine.2005.01.103_bib8","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1086\/379375","article-title":"Antibody to genome-derived neisserial antigen 2132, a Neisseria meningitidis candidate vaccine, confers protection against bacteremia in the absence of complement-mediated bactericidal activity","volume":"188","author":"Welsch","year":"2003","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2005.01.103_bib9","doi-asserted-by":"crossref","first-page":"6487","DOI":"10.4049\/jimmunol.167.11.6487","article-title":"A novel mimetic antigen eliciting protective antibody to Neisseria meningitidis","volume":"167","author":"Granoff","year":"2001","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2005.01.103_bib10","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1046\/j.1365-2958.2003.03770.x","article-title":"NarE: a novel ADP-ribosyltransferase from Neisseria meningitidis","volume":"50","author":"Masignani","year":"2003","journal-title":"Mol Microbiol"},{"issue":"6","key":"10.1016\/j.vaccine.2005.01.103_bib11","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1084\/jem.20021911","article-title":"Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870","volume":"197","author":"Masignani","year":"2003","journal-title":"J Exp Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05001532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05001532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,29]],"date-time":"2019-01-29T22:29:42Z","timestamp":1548800982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X05001532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":11,"alternative-id":["S0264410X05001532"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2005.01.103","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}